2018
Antenatal depression, psychotropic medication use, and inflammation among pregnant women
Miller E, Grobman W, Culhane J, Adam E, Buss C, Entringer S, Miller G, Wadhwa P, Keenan-Devlin L, Borders A. Antenatal depression, psychotropic medication use, and inflammation among pregnant women. Archives Of Women's Mental Health 2018, 21: 785-790. PMID: 29862416, PMCID: PMC6240365, DOI: 10.1007/s00737-018-0855-9.Peer-Reviewed Original ResearchConceptsAntenatal depressive symptomsInflammatory biomarkersPregnant womenProspective multicenter observational studyCross-sectional secondary analysisContext of pharmacotherapyHigher TNFα levelsMulticenter observational studyEpidemiologic Studies Depression ScalePsychotropic medication useLower TNFαPre-existing high levelsAntenatal depressionMedication useSerum TNFαTNFα levelsWeeks' gestationSelf-reported useDepression screenPsychotropic medicationsTNFα concentrationsMedical recordsPoor responseTherapeutic responseObservational study
2001
Maternal Stress is Associated With Bacterial Vaginosis in Human Pregnancy
Culhane J, Rauh V, McCollum K, Hogan V, Agnew K, Wadhwa P. Maternal Stress is Associated With Bacterial Vaginosis in Human Pregnancy. Maternal And Child Health Journal 2001, 5: 127-134. PMID: 11573838, DOI: 10.1023/a:1011305300690.Peer-Reviewed Original ResearchConceptsChronic maternal stressBacterial vaginosisMaternal stressRisk factorsMaternal infectionBV statusPresence of BVChronic stressMultivariable logistic regression modelHigher chronic stress levelsIntermediate vaginal floraAdverse perinatal outcomesBehavioral risk factorsMaternal sociodemographic variablesCohen's Perceived Stress ScaleModerate stress groupLogistic regression modelsRace/ethnicityLow stress groupPerinatal outcomesIndependent predictorsWeeks' gestationHigh stress groupHuman pregnancyPregnant women